ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,441,777, issued on Oct. 14, was assigned to Nxera Pharma UK Ltd. (Cambridge, Great Britain).
"GLP-1 receptor antagonists" was invented by Giles Albert Brown (Cambridge, Great Britain), Miles Stuart Congreve (Cambridge, Great Britain) and Conor Scully (Cambridge, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosures herein relate to novel compounds of formula (1): and salts thereof, wherein R1, AA1, AA2, LysR, X and Y are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of disorders associated with Glucagon-like peptide-1 (GLP-1) receptors."
The patent was filed on Oct. 14, 2019...